BRIACELL THERAPEUTICS CORP. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
BRIACELL THERAPEUTICS CORP. (BCTX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $13.65 million as of 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2023-12-14
- 2023-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $13.65M.
- 2023-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $21.25M.
- 2023-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $28.17M.
- 2023-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $33.50M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2023-10-31 | $13.65M 10-Q · filed 2023-12-14 |
| 2023-07-31 | $21.25M 10-Q · filed 2023-12-14 |
| 2023-04-30 | $28.17M 10-Q · filed 2023-06-14 |
| 2023-01-31 | $33.50M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $37.45M 10-Q · filed 2023-12-14 |
| 2022-07-31 | $41.04M 10-Q · filed 2023-12-14 |
| 2022-04-30 | $44.53M 10-Q · filed 2023-06-14 |
| 2022-01-31 | $47.98M 10-Q · filed 2023-03-16 |
| 2021-10-31 | $55.49M 10-Q · filed 2022-12-14 |
| 2021-07-31 | $57.27M 10-K · filed 2023-10-25 |
| 2020-07-31 | $21.25K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |